intellectual property

The paper discusses intellectual property protection in the case of pharmaceutical companies selling AIDS medication to less developed countries at cost.

The paper offers three examples to illustrate Nelsons serious doubts about the way in which intellectual property has been developing.

The paper offers a theoretical treatment of information disclosure through patenting. The author considers a signaling model in which two domestic firms disclose their competencies to a foreign firm and demonstrates that subsidizing the costs of patent applications has no impact on the outcome.

The paper examines whether patenting increases the private incentives to innovate in manufacturing. To study this issue, the authors build a model in which the value of an innovation depends both on the type of innovation implemented (product, process) and on the existence of a patent protection or not.

Patent citation data are used in a growing body of economics and business research on technological diffusion. The paper assesses the legitimacy of using European patent citations as a measure of technology flows, using information from the Community Innovation Survey collected by the French Service des Statistiques Industrielles.

Using data on three million U.S. patents granted between 1967 and 1999, and their citations received between 1975 and 2002, the authors construct a number of measures of general purpose technolgies, including generality, number of citations, and patent class growth, for patents themselves and for the patents that cite the patents.

The paper explores the spatial distribution of regional technology indicators in the European Union over the last decade and its impact on cohesion. Findings indicate that public research and development spending and patent applications have converged among regions during the nineties.

The paper focuses on the analysis of size distributions of innovations, which are known to be highly skewed. The authors also study self-assessed reports of patented innovation values using two very recent patent valuation datasets from the Netherlands and the UK, as well as a small dataset of patent license revenues of Harvard University.

The article offers twenty guidelines to help valuators understand the highly detailed and expensive process of patent pricing that usually requires the input of lawyers and advisers with specific technical knowledge and experience.

The paper discusses the reasons why SMEs may be disavdantaged in their use of intellectual property as opposed to more general disadvantages that may incur over the whole course of innovation.